Apnimed Announces Launch of Joint Venture with Shionogi to

$150M transaction supporting early and clinical-stage pipeline development in OSA and related sleep disorders to find oral pharmacologic solutions for...

Related Keywords

United States ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,Americans ,Wendy Gabel ,Larry Miller ,Apnimed Inc ,Linkedin ,Shionogi Co Ltd ,Shionogi Apnimed Sleep Science ,Apnimed Sleep Science ,Chief Executive Officer ,Sleep Apnea ,Apnimed ,Nc ,Shionogi ,Joint Venture ,Obstructive Sleep Apnea ,Sleep Disorders ,Drug Discovery ,Research ,Clincial Trials ,